Questions about Rheumatoid Arthritis? Get answers from our expert.

Diclofenac Pregnancy and Breastfeeding Warnings

Diclofenac is also known as: Cambia, Cataflam, Voltaren, Voltaren-XR, Zipsor, Zorvolex

Diclofenac Pregnancy Warnings

Diclofenac has been assigned to pregnancy category C prior to 30 weeks gestation and to category D starting at 30 weeks of gestation by the FDA. Use of diclofenac or other NSAIDs late in pregnancy (after 30 weeks gestation) may cause premature closure of the ductus arteriosus and prolong labor and delivery. If diclofenac is used after 30 weeks of pregnancy, the patient should be apprised of the potential hazard to the fetus. Animal studies have failed to reveal evidence of teratogenicity, despite the induction of maternal toxicity and fetal toxicity. There are no controlled data in human pregnancy. Diclofenac should be given during pregnancy only when the potential benefits outweigh the potential risks.

Diclofenac Breastfeeding Warnings

It is not known whether diclofenac is excreted in human milk; however, there is a case report in the literature indicating that diclofenac can be detected at low levels in breast milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from diclofenac, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web4)